The MSH2 gene helps cells repair copy errors in DNA, the body’s instruction code. If it does not work properly, errors can build up and can lead to Lynch syndrome, an inherited condition linked to a higher risk of colorectal, uterine, and some other cancers. Some people first learn about this gene when genetic testing is done after a strong family history of these cancers.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the working parts of cells. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
MSH2Gene function
What if the gene works
The MSH2 gene helps repair small DNA copying mistakes, helping cells keep their genetic instructions stable and lowering the buildup of new variants.
Risk
What if the gene does not work
Some variants in the MSH2 gene raise the chance of Lynch syndrome, which increases the risk of colorectal, uterine, and some other cancers. More severe or two nonworking variants can cause earlier, broader features, including childhood constitutional mismatch repair deficiency.
Treatment
What does that mean for your treatment
A pathogenic variant in the MSH2 gene can affect treatment because related tumors often have mismatch repair deficiency and may respond to immune checkpoint inhibitors such as pembrolizumab or dostarlimab. In colon cancer, this result can also influence whether standard chemotherapy is likely to help.
Conditions associated with MSH2
Gene function
What if the gene works
Every day, your cells copy huge amounts of DNA. The MSH2 gene helps them spot copying slips and direct the right repair steps, which is a key part of how the MSH2 gene helps repair DNA. This keeps the genetic instructions in each cell more consistent over time.
The MSH2 gene helps cells find mismatched DNA letters and small extra or missing pieces after DNA is copied. It provides an early quality check before those slips become part of the cell’s permanent instructions.
Inside your cells, MSH2 pairs with partner proteins to confirm a copying mistake and bring in repair helpers. Those helpers remove the faulty stretch and replace it with the correct DNA sequence.
By correcting routine copying errors, the MSH2 gene supports accurate DNA replication when cells divide. This helps many tissues keep a stable set of genetic instructions over time.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MSH2 gene can weaken or shut down a DNA repair protein, so copying mistakes build up in cells. Some changes slightly alter the protein’s shape, stability, or ability to link with partner proteins, while more severe variants stop it from being made or leave it unable to work. This helps explain how MSH2 gene variants affect DNA repair, and why more disruptive variants are often linked to a higher chance of Lynch syndrome and, in some families, earlier cancer onset.
How variants are linked to conditions
Variants in the MSH2 gene cause Lynch syndrome, so information about the MSH2 gene and Lynch syndrome often centers on inherited cancer risk. People with a pathogenic MSH2 variant have a confirmed Lynch syndrome diagnosis and a higher chance of colorectal, endometrial, ovarian, stomach, urinary tract, and some other cancers. Some also develop sebaceous skin tumors as part of Lynch syndrome, a pattern historically called Muir-Torre syndrome.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In other cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
With an inherited harmful change in the MSH2 gene, the chance of certain cancers is already high, and it can vary by age, sex, and family history. Smoking can further raise the risk of some Lynch syndrome cancers. The most important step is regular cancer screening and paying attention to new symptoms early.
Inheritance of MSH2 variants
The inheritance pattern for MSH2-related conditions depends on the specific condition. Most often, a harmful variant in one copy of the MSH2 gene is inherited in an autosomal dominant way, which means a parent carrying it can pass it to a child with a 50% chance, as seen in Lynch syndrome; some cases also result from a new variant not inherited from either parent. More rarely, when a person inherits harmful variants in both copies of the MSH2 gene, the condition follows an autosomal recessive pattern, as in constitutional mismatch repair deficiency.
What does my MSH2 result mean for my family?
For many living with an MSH2 change linked to Lynch syndrome, close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to learn their own status. MSH2 can also be tied to a rarer childhood condition when a child inherits a changed copy from both parents, so family meaning depends on which MSH2-related condition applies to the result. In some families, a Lynch syndrome-related MSH2 change can start new in one person rather than being passed down from a parent.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the MSH2 gene, a lab can analyze DNA from a blood or saliva sample. Genetic testing for MSH2 variants reads the gene’s DNA code and compares it with the usual sequence to identify changes that may help explain inherited cancer risk in some families.
When should I consider getting a genetic test?
Genetic testing for the MSH2 gene is worth considering if you or close relatives have had colon, womb, or certain other cancers, especially at a young age or more than once. It can help show whether Lynch syndrome runs in the family and may guide cancer screening for relatives.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although how much it reveals depends on the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, affect how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds at the drug’s target, so the same treatment may work better for one person than for another. This is common and can influence how well a medicine helps, how long its effects last, or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. By studying the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence either how strongly a drug works or how the body processes it. Understanding this can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the MSH2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication response, so general concerns about side effects, treatment choices, or family cancer history are best discussed with your doctor. In cancer care, MSH2 is studied mainly because tumors that lose MSH2 can respond differently to some treatments, especially certain immunotherapy medicines.
History
The MSH2 gene became a turning point in the history of inherited cancer research during the 1990s, when scientists linked variants in this gene to Lynch syndrome, a hereditary condition tied to higher risks of colorectal and some other cancers. Before that, many affected families were recognized only by striking patterns of cancer across generations. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition helped move medicine from family history alone to gene based diagnosis. The discovery of MSH2, along with related mismatch repair genes, reshaped how doctors classify certain colon and uterine cancers. These historical steps shaped today’s understanding of inherited cancer risk and tumor testing.